Joel Bolomboy’s biography, net worth, fact, career, awards and life story

Intro Basketball player (1994-)
Is Athlete 
Basketball player 
From United States of America 
Russia 
Type Sports 
Gender male
Birth 28 January 1994, Donetsk, Donetsk Oblast, Ukraine
Age: 26 years
Star sign Aquarius
Stats
Height: 206 cm
Weight: 235 lbs
Education
Central High School
Sports Teams
PBC CSKA Moscow

Joel Bolomboy (born January 28, 1994) is a Russian professional basketball player for CSKA Moscow of the VTB United League and the EuroLeague. He played college basketball for the Weber State Wildcats, where he was named Big Sky Conference Player of the Year in 2016. He was born in Ukraine but received Russian citizenship in 2018.

Early life and college career

Bolomboy was born in Donetsk, Ukraine to a Congolese father and a Russian mother of Tatar origin, went to high school at Keller Central High School in Fort Worth, Texas, and chose Weber State for college despite interest from larger schools such as Clemson, Auburn and Florida State. During his college career, Bolomboy became the all-time leading rebounder in Weber State and Big Sky Conference history.

While always a strong rebounder, Bolomboy increased his scoring average in the 2015–16 season, averaging 17.9 points per game to go along with 12.8 rebounds per game. Following the season, Bolomboy was named first-team All-Big Sky Conference, as well as the league’s Player of the Year and Defensive Player of the Year.

Professional career

Utah Jazz (2016–2017)

On June 23, 2016, Bolomboy was selected by the Utah Jazz with the 52nd pick in the 2016 NBA draft. On August 19, 2016, he signed with the Jazz. He made his NBA debut on October 30, 2016, recording three points, one rebound, one assist, one steal and one block in four minutes off the bench in an 88–75 loss to the Los Angeles Clippers. During his rookie season, Bolomboy had multiple assignments with the Salt Lake City Stars, Utah’s D-League affiliate. In 26 games with the Stars, he averaged 16.5 points and 13.3 rebounds per contest.

On October 16, 2017 Bolomboy was waived by the Jazz.

Milwaukee Bucks / Wisconsin Herd (2017–2018)

On October 20, 2017, Bolomboy signed a two-way contract with the Milwaukee Bucks via their NBA G League affiliate the Wisconsin Herd. Throughout the length of his deal, he would split his playing time between the Bucks and their G League affiliate. However, Bolomboy would be waived from the team on January 7, 2018, after signing Xavier Munford to a two-way contract of his own accord. On January 10, 2018, Bolomboy was reacquired by the Wisconsin Herd.

CSKA Moscow (2018–present)

Bolomboy was acquired by CSKA Moscow of the VTB United League on August 8, 2018, signing a three-year deal. On March 2, 2020, he signed a two-year extension with the club.

NBA career statistics

  GP Games played   GS  Games started  MPG  Minutes per game
 FG%  Field goal percentage  3P%  3-point field goal percentage  FT%  Free throw percentage
 RPG  Rebounds per game  APG  Assists per game  SPG  Steals per game
 BPG  Blocks per game  PPG  Points per game  Bold  Career high

Regular season

Year Team GP GS MPG FG% 3P% FT% RPG APG SPG BPG PPG
2016–17 Utah 12 0 4.4 .563 .250 ‘.500 1.4 .2 .1 .2 1.8
2017–18 Milwaukee 6 0 6.3 .500 .000 .500 1.7 .0 .3 .0 1.5
Career 18 0 5.1 .545 .200 .500 1.5 .1 .2 .1 1.7

Playoffs

Year Team GP GS MPG FG% 3P% FT% RPG APG SPG BPG PPG
2017 Utah 2 0 4.5 .667 .000 .000 1.0 .0 .0 .5 2.0
Career 2 0 4.5 .667 .000 .000 1.0 .0 .0 .5 2.0

EuroLeague

Year Team GP GS MPG FG% 3P% FT% RPG APG SPG BPG PPG PIR
2018–19 CSKA Moscow 28 5 9.1 .564 .462 .600 1.9 .4 .1 .0 2.6 2.9
2019–20 27 1 16.5 .562 .325 .743 4.0 .5 .3 .1 5.4 7.6
You May Also Like

Stephen Saad’s net worth, biography, fact, career, awards and life story

Stephen Saad net worth: Stephen Saad is a South African billionaire who has a net worth of $1.9 billion. Stephen Saad is the co-founder of Aspen Pharmacare, South Africa’s leading publicly-traded drug manufacturer on the Johannesburg Stock Exchange. At the start of 2012, Aspen’s revenues took a hit along with the entrance of new generic drug manufacturers to the market. However, Aspen stakes have risen throughout 2012, making Saad a billionaire as his company established relationships with global pharmacy innovators that often see generic companies as rivals. Now GlaxoSmithKline, the world’s fourth-largest pharmaceutical company, is Aspen’s largest shareholder. Stephen entered the world of billionaires at age 29 after he gave his share in the drug business Covan Zurich for $3 million. In 2011 Aspen acquired the global rights to produce some of GSK’s smaller brands. Even though he doesn’t have too much free time on his hands, Saad often goes to Exeter, his private game reserve at Sabi Sands, which is adjacent to the largest national park in South Africa called Kruger National Park.
Read More